Monday, 3 April 2017

Don't Write Off Pharma's Nightmare Scenario

Drug-price rhetoric translating into law is nearly unthinkable for investors, but the risk still shouldn’t be ignored.

from WSJ.com: Markets http://ift.tt/2n4BFxj
via https://ifttt.com/ IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)